Abstract
AbstractTransportability of findings across research domains is challenging, with a substantial share of biomedical research not translating well to clinical medicine. This lack of transportability may improve by focus on ‘scope validity’: the extent to which an experimental target matches the intended application. Positioned amidst construct validity and external validity, more awareness and better articulation of the scope of preclinical investigations could support epistemic reasoning as well as knowledge utilisation in biomedical research. Scope validity necessitates a clear notion among researchers about their position within the broader field of study, a task that in an era of superspecialisation is as daunting as it is imperative.
Publisher
Springer International Publishing
Reference12 articles.
1. Clarkson, Josie. 2022. Dementia in other animals. Dementia Platform UK. https://www.dementiasplatform.uk/news-and-media/blog/dementia-in-other-animals. Accessed 1 Aug 2023.
2. Darweesh, Sirwan K.L., Vincentius J.A. Verlinden, Bruno H. Stricker, Albert Hofman, Peter J. Koudstaal, and M. Arfan Ikram. 2017. Trajectories of prediagnostic functioning in Parkinson’s disease. Brain 140 (2): 429–441. https://doi.org/10.1093/brain/aww291.
3. Laudan, Larry. 1990. Demystifying underdetermination. In Scientific theories, ed. C. Wade, 267–297. Minneapolis: University of Minnesota Press.
4. Phillips, Christopher J. 2020. Precision medicine and its imprecise history. Harvard Data Science Review 2 (1). https://doi.org/10.1162/99608f92.3e85b56a.
5. Quine, William V. 1970. On the reasons for indeterminacy of translation. Journal of Philosophy 67 (6): 178–183.